Pirfenidone prolongs survival, preserves lung function in idiopathic pulmonary fibrosis (ASCEND)
www.pulmccm.org
For idiopathic pulmonary fibrosis treatment pirfenidone, the third time wasn't the charm; the fourth was. After reducing decline in forced vital capacity over one year in a Japanese trial of 275 IPF patients, pirfenidone went one-and-one in the multinational
Pirfenidone prolongs survival, preserves lung function in idiopathic pulmonary fibrosis (ASCEND)
Pirfenidone prolongs survival, preserves lung…
Pirfenidone prolongs survival, preserves lung function in idiopathic pulmonary fibrosis (ASCEND)
For idiopathic pulmonary fibrosis treatment pirfenidone, the third time wasn't the charm; the fourth was. After reducing decline in forced vital capacity over one year in a Japanese trial of 275 IPF patients, pirfenidone went one-and-one in the multinational